A Seven-Year Clinical Evaluation of Soft-Tissue Effects of Hydroxylapatite-Coated vs. Uncoated Subperiosteal Implants

1. Scientific Reference

• Study Title: A seven-year clinical evaluation of soft-tissue effects of hydroxylapatite-coated vs. uncoated subperiosteal implants
• Authors: R. H. Fettig, J. F. Kay
• Journal: Not specified in the provided information.
• Year of Publication: Not specified in the provided information.
• DOI: Not specified in the provided information.
• PMID: 7932855

2. Scientific Background

Subperiosteal implants have historically represented one of the available treatment options for the rehabilitation of partially and completely edentulous patients. As implant dentistry evolved, increasing attention was directed toward improving the biological interaction between implant materials and surrounding tissues, with the goal of enhancing long-term clinical stability.

Surface modification became one of the strategies investigated to optimize implant performance. Hydroxylapatite coatings were introduced with the expectation that they could improve tissue integration by modifying the biological interface between metallic implant frameworks and host tissues. While much interest has traditionally focused on osseous integration, the condition of the peri-implant soft tissues is equally important because it contributes to the maintenance of a healthy transmucosal barrier around implant components.

Within this context, the present study explores whether hydroxylapatite surface coating influences the intermediate-term behavior of soft tissues surrounding subperiosteal implants compared with conventional uncoated metallic frameworks.

3. Study Objective

The primary objective of this clinical investigation was to compare the intermediate-term soft-tissue response associated with hydroxylapatite-coated subperiosteal implants and conventional uncoated subperiosteal implants after comparable periods of clinical function.

Rather than focusing exclusively on implant survival, the authors sought to determine whether surface coating with hydroxylapatite could influence peri-implant soft-tissue healing and long-term tissue health around transmucosal abutment posts.

4. Methodology

Based on the information available in the abstract, this was a comparative clinical follow-up study evaluating two types of subperiosteal implant frameworks.

Four hydroxylapatite-coated implants and four uncoated metallic implants were monitored for approximately six years. During follow-up, one participant carrying a coated implant died after five years, preventing further evaluation of that case. In the uncoated group, one implant required removal after four years because of persistent soft-tissue dehiscence around the post region.

The remaining implants continued to be clinically evaluated. The abstract does not specify patient demographics, inclusion criteria, surgical protocol, clinical examination methods, statistical analyses, or predefined outcome measures.

5. Main Findings

The clinical observations reported by the authors suggest that both implant designs generally demonstrated satisfactory intermediate-term performance among the implants that completed follow-up. Early postoperative healing appeared to progress more rapidly in the hydroxylapatite-coated group, indicating a potentially more favorable biological response during the initial healing phase.

Differences became more apparent when peri-implant soft tissues were examined. According to the authors, coated implants consistently exhibited a healthier and more stable soft-tissue attachment surrounding the transmucosal abutment posts. In addition, no post-implantation strut dehiscence was reported in the hydroxylapatite-coated group during the available observation period.

Conversely, one uncoated implant required explantation because persistent dehiscence could not be resolved clinically. The authors also emphasize that changes involving hard tissues may not always be detectable through direct clinical observation alone, highlighting the importance of considering both soft- and hard-tissue responses when evaluating implant performance.

Overall, the findings suggest that hydroxylapatite coating may provide incremental biological advantages over conventional metallic subperiosteal implants, particularly regarding peri-implant soft-tissue behavior, while potentially contributing to favorable hard-tissue responses as well.

6. Clinical Analysis

Although subperiosteal implants are less frequently discussed in contemporary implantology than endosseous implant systems, this study offers valuable insight into how implant surface characteristics may influence the biological behavior of peri-implant soft tissues. Rather than attempting to demonstrate a dramatic improvement in overall clinical success, the investigation focuses on a specific aspect of implant performance: the quality of the soft-tissue interface surrounding transmucosal components.

The observations suggest that hydroxylapatite coating may promote a more stable and healthier peri-implant soft-tissue seal compared with conventional metallic frameworks. Clinically, this finding is relevant because the integrity of the soft-tissue barrier plays an important role in protecting deeper supporting structures and maintaining long-term implant health. The absence of reported strut dehiscence among the coated implants further supports the hypothesis that surface modification may positively influence tissue adaptation.

However, these findings should be interpreted cautiously. The study included only a limited number of implants, and one implant in each group was lost from long-term evaluation for different reasons. Furthermore, the abstract does not describe standardized clinical indices, radiographic assessment methods, statistical analyses, or objective measurements of tissue health. Consequently, while the reported trends appear favorable for hydroxylapatite-coated implants, they should be regarded as preliminary clinical observations rather than definitive evidence of superiority.

From a clinical perspective, the study highlights the potential importance of implant surface technology in addition to mechanical design when evaluating long-term biological performance.

7. Clinical Applications

The findings may be relevant for clinicians involved in the rehabilitation of partially or completely edentulous patients treated with subperiosteal implants. In particular, the study draws attention to the potential influence of implant surface characteristics on peri-implant soft-tissue quality during long-term maintenance.

Although the abstract does not support extending these observations to other implant systems or surgical protocols, it suggests that hydroxylapatite coating may contribute to improved soft-tissue adaptation around transmucosal abutments. These observations may also encourage further investigation into biomaterial surface modifications designed to enhance the biological integration of implant-supported rehabilitations.

The available data should not be interpreted as establishing a universal clinical recommendation but rather as supporting continued research into biologically optimized implant surfaces.

8. Level of Evidence, Limitations and Transparency

Based on the available information, this publication represents a comparative clinical follow-up study involving a limited number of implants. The corresponding level of evidence is therefore lower than that provided by randomized controlled trials, systematic reviews, or meta-analyses.

Several methodological limitations should be considered. The sample size was small, one patient was unavailable for complete follow-up because of death, and one implant required removal during the observation period. The abstract does not provide details regarding patient selection, examiner calibration, statistical analysis, or predefined outcome variables.

No information regarding funding sources, financial disclosures, or potential conflicts of interest is included in the provided abstract.

These limitations warrant cautious interpretation of the reported findings and emphasize the need for confirmation through larger prospective clinical investigations.

9. Key Study Points

• Study design: Comparative clinical follow-up study.
• Level of evidence: Clinical observational evidence with a limited sample size.
• Study population: Partially and completely edentulous patients treated with subperiosteal implants.
• Number of implants: Eight implants (four hydroxylapatite-coated and four uncoated).
• Follow-up period: Approximately six years, with a seven-year clinical evaluation indicated by the study title.
• Primary outcome: Intermediate-term peri-implant soft-tissue response.
• Main findings: Hydroxylapatite-coated implants demonstrated a healthier soft-tissue seal around transmucosal abutments and no reported strut dehiscence during the available follow-up.
• Scientific conclusion: Hydroxylapatite coating appears to provide incremental improvements in biological performance compared with uncoated metallic subperiosteal implants, particularly regarding soft-tissue response.
• Limitations: Small sample size, incomplete follow-up, limited methodological information, and absence of detailed statistical reporting.

10. Scientific Impact

This study contributes to the understanding of how implant surface modifications may influence biological responses beyond osseous integration alone. By specifically examining peri-implant soft tissues, the authors broaden the discussion surrounding implant success to include the quality of the transmucosal interface, an aspect that remains clinically relevant for long-term implant maintenance.

Although the investigation does not provide definitive evidence because of its limited scale, it offers early clinical observations supporting the concept that biomaterial surface engineering may positively affect tissue behavior. These findings contribute to the historical development of implant surface technologies and illustrate an important stage in the evolution of biologically oriented implant design.

Rather than establishing a new standard of care, the study provides preliminary clinical evidence that may serve as a foundation for future research involving larger patient cohorts, standardized outcome measures, and more robust comparative methodologies.

11. Editorial Conclusion

This clinical investigation suggests that hydroxylapatite coating may enhance the biological interaction between subperiosteal implants and surrounding soft tissues during intermediate-term follow-up. The reported improvement in peri-implant soft-tissue quality, together with the absence of strut dehiscence among coated implants, supports continued interest in implant surface modification as a strategy for optimizing biological performance. Nevertheless, the limited sample size and incomplete methodological details require that these findings be interpreted with appropriate scientific caution until confirmed by larger and more rigorous clinical studies.